Abstract
Arterial hypertension and osteoporosis represent multifactorial disorders, where genetic and environmental factors culminate in the development of pathogenesis. Recent studies suggest that angiotensin II, the main active peptide produced by the renin-angiotensin system (RAS), stimulates osteoclast differentiation and activity, influencing bone metabolism and contributing to the imbalance …